Brentuximab vedotin in advanced-stage mycosis fungoides/Sézary syndrome with low CD30 expression: real-world data from the German Cutaneous Lymphoma Network
Simple SummaryAdvanced-stage mycosis fungoides (MF) and Sézary syndrome (SS) are aggressive cutaneous T-cell lymphomas with limited treatment options ...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
28 December 2025
|
| In: |
Cancers
Year: 2025, Volume: 18, Issue: 1, Pages: 1-12 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers18010097 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.3390/cancers18010097 Verlag, kostenfrei, Volltext: https://www.mdpi.com/2072-6694/18/1/97 |
| Author Notes: | Christoph Blazejak, Mathias Oymanns, René Stranzenbach, Uwe Hillen, Christina Mitteldorf, Jan P. Nicolay, Marion Wobser, Philipp Schrüfer, Janika Gosmann, Ulrike Wehkamp, Nina Booken, Alexander Kreuter, Edgar Dippel, Claus-Detlev Klemke, Maria Weyermann, Rudolf Stadler and Chalid Assaf |
| Summary: | Simple SummaryAdvanced-stage mycosis fungoides (MF) and Sézary syndrome (SS) are aggressive cutaneous T-cell lymphomas with limited treatment options ... |
|---|---|
| Item Description: | Gesehen am 19.02.2026 |
| Physical Description: | Online Resource |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers18010097 |